JDOC holdings

All 66 positions of JPMorgan Healthcare Leaders ETF.

Download CSV

Positions

Top 10 weight

46.6%

Effective holdings

31.0

1 / sum of squared weights

In stocks

98.9%

In bonds

0.0%

Outside the US

25.6%

Asset mix

Equity98.9%
Cash0.6%

Sectors

75% of stocks classified

Health Care66.0%
Technology5.1%
Consumer Staples2.7%

Countries

United States73.4%
United Kingdom5.2%
Switzerland4.8%
Denmark4.1%
Japan3.0%
Netherlands2.4%
Belgium2.0%
Germany2.0%
Israel1.4%
Ireland0.6%
Canada0.3%

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	LLYEli Lilly & Co.	Equity	6.81%	$758K	811	US
2	ABBVABBVIE INC.	Equity	6.58%	$732K	3,464	US
3	JNJJohnson & Johnson	Equity	6.20%	$690K	3,001	US
4	UNHUNITEDHEALTH GROUP INCORPORATED (Delaware)	Equity	5.83%	$649K	1,751	US
5	AstraZeneca plc	Equity	4.57%	$508K	2,677	GB
6	MRKMerck & Co., Inc.	Equity	4.21%	$468K	4,289	US
7	BMYBristol-Myers Squibb Co.	Equity	3.50%	$389K	6,427	US
8	TMOThermo Fisher Scientific, Inc.	Equity	3.19%	$354K	740	US
9	ISRGIntuitive Surgical Inc.	Equity	2.96%	$329K	719	US
10	CVSCVS HEALTH CORPORATION	Equity	2.71%	$301K	3,618	US
11	Novo Nordisk A/S	Equity	2.65%	$295K	6,943	DK
12	Roche Holding AG	Equity	2.65%	$295K	723	CH
13	Hoya Corp.	Equity	2.35%	$261K	1,400	JP
14	REGNRegeneron Pharmaceuticals Inc	Equity	2.19%	$243K	344	US
15	BSXBoston Scientific Corp.	Equity	2.04%	$227K	3,946	US
16	UCB SA	Equity	1.97%	$219K	803	BE
17	VRTXVertex Pharmaceuticals Inc	Equity	1.96%	$218K	510	US
18	DHRDanaher Corporation	Equity	1.90%	$212K	1,184	US
19	EWEdwards Lifesciences Corp	Equity	1.83%	$203K	2,435	US
20	MCKMcKesson Corporation	Equity	1.78%	$198K	243	US
21	SYKStryker Corporation	Equity	1.59%	$177K	562	US
22	Argenx SE	Equity	1.54%	$171K	218	NL
23	Teva Pharmaceutical Industries Ltd.	Equity	1.41%	$157K	4,466	IL
24	CAHCardinal Health, Inc.	Equity	1.38%	$154K	796	US
25	CNCCentene Corporation	Equity	1.32%	$147K	2,739	US
26	BIIBBiogen Inc. Common Stock	Equity	1.30%	$145K	764	US
27	ZTSZOETIS INC.	Equity	1.17%	$131K	1,136	US
28	UTHRUnited Therapeutics Corp	Equity	1.16%	$129K	226	US
29	Lonza Group AG	Equity	1.11%	$123K	200	CH
30	Novartis AG	Equity	1.04%	$116K	783	CH
31	Fresenius SE & Co. KGaA	Equity	1.04%	$115K	2,383	DE
32	IQVIQVIA Holdings Inc.	Equity	1.03%	$115K	726	US
33	Sartorius AG	Equity	0.91%	$102K	398	DE
34	SYRESpyre Therapeutics, Inc. Common Stock	Equity	0.89%	$99K	1,327	US
35	APGEApogee Therapeutics, Inc. Common Stock	Equity	0.86%	$95K	1,152	US
36	IONSIonis Pharmaceuticals, Inc. Common Stock	Equity	0.84%	$94K	1,257	US
37	Argenx SE	Equity	0.82%	$91K	116	NL
38	CGONCG Oncology, Inc. Common stock	Equity	0.78%	$87K	1,304	US
39	Ascendis Pharma A/S	Equity	0.71%	$79K	343	DK
40	ALGNAlign Technology Inc	Equity	0.69%	$77K	437	US
41	IMNMImmunome, Inc.	Equity	0.69%	$77K	3,351	US
42	DYNDyne Therapeutics, Inc. Common Stock	Equity	0.67%	$75K	4,266	US
43	JPMorgan Securities Lending Money Market Fund	Cash	0.64%	$71K	71,313	US
44	DXCMDexCom, Inc.	Equity	0.64%	$71K	1,196	US
45	NBIXNeurocrine Biosciences Inc	Equity	0.63%	$70K	533	US
46	Genmab A/S	Equity	0.63%	$70K	265	DK
47	Daiichi Sankyo Co. Ltd.	Equity	0.61%	$68K	4,200	JP
48	Convatec Group plc	Equity	0.61%	$67K	23,481	GB
49	CIThe Cigna Group	Equity	0.60%	$67K	231	US
50	Medtronic plc	Equity	0.59%	$65K	808	IE
51	ALMSAlumis Inc. Common Stock	Equity	0.54%	$60K	2,446	US
52	NUVLNuvalent, Inc. Class A Common Stock	Equity	0.53%	$59K	584	US
53	TECHBio-Techne Corp.	Equity	0.42%	$47K	843	US
54	SIONSionna Therapeutics, Inc. Common Stock	Equity	0.42%	$46K	1,201	US
55	IRONDisc Medicine, Inc. Common Stock	Equity	0.38%	$42K	636	US
56	ALNYAlnylam Pharmaceuticals, Inc.	Equity	0.31%	$35K	112	US
57	VRDNViridian Therapeutics, Inc. Common Stock	Equity	0.28%	$31K	2,323	US
58	EVMNEvommune, Inc.	Equity	0.27%	$30K	1,260	US
59	XENEXenon Pharmaceuticals Inc	Equity	0.27%	$30K	535	CA
60	HCAHCA Healthcare, Inc.	Equity	0.27%	$30K	68	US
61	GMABGenmab A/S ADS	Equity	0.12%	$14K	523	DK
62	Swiss Franc	Cash	0.00%	$0	0	CH
63	Danish Krone	Cash	0.00%	$0	0	DK
64	Japanese Yen	Cash	-0.00%	−$0	-1	JP
65	British Pound	Cash	-0.00%	−$0	0	GB
66	EURO	Cash	-0.00%	−$1	-1

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Exit	Roche Holding AG	2.92%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	Roche Holding AG	—	2.65%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	Medtronic plc	3.10%	0.59%	−77.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	UNHUnitedHealth Group, Inc.	3.49%	5.83%	+23.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	EssilorLuxottica SA	1.92%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ISRGIntuitive Surgical, Inc.	1.35%	2.96%	+129.8%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	TMOThermo Fisher Scientific, Inc.	1.67%	3.19%	+118.8%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	CNCCentene Corp.	—	1.32%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	Argenx SE	2.09%	0.82%	−60.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	DHRDanaher Corp.	3.16%	1.90%	−29.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	JNJJohnson & Johnson	7.43%	6.20%	−21.4%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ZTSZoetis, Inc.	—	1.17%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ABBVAbbVie, Inc.	5.41%	6.58%	+22.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	BMYBristol-Myers Squibb Co.	2.43%	3.50%	+24.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	AXSMAxsome Therapeutics, Inc.	0.90%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	MRKMerck & Co., Inc.	5.11%	4.21%	−20.8%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	SYRESpyre Therapeutics, Inc.	—	0.89%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	Lonza Group AG	1.95%	1.11%	−40.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	ASNDAscendis Pharma A/S	0.77%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	Ascendis Pharma A/S	—	0.71%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	DXCMDexcom, Inc.	—	0.64%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	ALMSAlumis, Inc.	—	0.54%	—	Jan 31, 2026 → Apr 30, 2026 SEC
New position	NUVLNuvalent, Inc.	—	0.53%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	RVMDRevolution Medicines, Inc.	0.50%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	WATWaters Corp.	0.49%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	CYTKCytokinetics, Inc.	0.49%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	UTHRUnited Therapeutics Corp.	0.73%	1.16%	+24.8%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	SIONSionna Therapeutics, Inc.	—	0.42%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	BSXBoston Scientific Corp.	2.42%	2.04%	+30.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	BIIBBiogen, Inc.	0.94%	1.30%	+24.7%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	TERNTerns Pharmaceuticals, Inc.	0.36%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	MCKMcKesson Corp.	2.09%	1.78%	−17.4%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	IRONDisc Medicine, Inc.	0.67%	0.38%	−37.1%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	CAHCardinal Health, Inc.	1.66%	1.38%	−12.0%	Jan 31, 2026 → Apr 30, 2026 SEC
New position	EVMNEvommune, Inc.	—	0.27%	—	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	ALGNAlign Technology, Inc.	0.42%	0.69%	+43.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	AstraZeneca plc	4.76%	4.57%	−10.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	CICigna Group (The)	0.44%	0.60%	+22.2%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	XENEXenon Pharmaceuticals, Inc.	0.43%	0.27%	−56.0%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	NBIXNeurocrine Biosciences, Inc.	0.77%	0.63%	−19.6%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	VRTXVertex Pharmaceuticals, Inc.	1.84%	1.96%	+11.3%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	Novartis AG	1.14%	1.04%	−12.5%	Jan 31, 2026 → Apr 30, 2026 SEC
Increase	UCB SA	1.89%	1.97%	+10.8%	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	HCAHCA Healthcare, Inc.	0.33%	0.27%	−14.9%	Jan 31, 2026 → Apr 30, 2026 SEC
Exit	LEGNLegend Biotech Corp.	0.03%	—	—	Jan 31, 2026 → Apr 30, 2026 SEC
Decrease	APGEApogee Therapeutics, Inc.	0.83%	0.86%	−22.5%	Jan 31, 2026 → Apr 30, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.